Jonathan Sterne
@jonathanasterne
Followers
1K
Following
862
Media
76
Statuses
1K
Thanks to an amazing effort by a fantastic international team, version 2 of the #Cochrane tool for assessing risk of bias in #randomized #trials (#ROB2) has just been published in @bmj_latest. Download from @_MiguelHernan
4
125
192
RT @venexia: 🚨 Funded PhD opportunity 🚨 Work with large-scale electronic health record data from #OpenSAFELY to optimise vaccine effectiven….
0
1
0
RT @HJHansford: A great privilege to have Prof @jonathanasterne at @PainIMPACTNeuRA to talk about assessing risk of bias in randomised tria….
0
2
0
RT @vicbiostat: We're off and away with Summer School 2025!. Jonathan Sterne is leading our Advanced causal inference course, ably assisted….
0
1
0
RT @_MiguelHernan: 1/.That "immortal time" is so frequent in survival analyses for #causalinference is fascinating. Because "immortal time….
0
75
0
RT @BrisHealthSci: New Year training goals? Explore our online intensive short courses for researchers and healthcare researchers - search….
0
11
0
RT @CAUSALab: The @CAUSALab Methods Series at @karolinskainst is back!. @jonathanasterne @BristolUni kicks off Fall 2024 with a virtual tal….
0
16
0
RT @BristolBRC: 📢New paper in @JAMAPsych.Incidence of mental illnesses in unvaccinated people increased for up to one year after severe COV….
0
7
0
RT @amibanerjee1: Our latest research:Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults….
nature.com
Nature Communications - COVID-19 vaccines have been associated with rare cardiovascular and thrombotic complications. Here, the authors use population-based longitudinal electronic health record...
0
11
0
RT @EastwoodSophie: Fab to work with @KurtSci1994 @venexia @jonathanasterne Nish Chaturvedi @MRCLHA Rachel Denholm & others @OpenSAFELY….
0
5
0
RT @kamleshkhunti: Increased incidence of T2 diabetes after COVID-19 in people who were hospitalised with #Covid_19 . Reduced risk in thos….
0
5
0
RT @BristolBRC: Our Director's Fund is supporting 3 new projects looking at predicting postoperative complications, empowering young people….
0
3
0
RT @_MiguelHernan: The @TARGETGuideline team needs your help. If you work on #causalinference from observational data, please get involved….
0
19
0
RT @BristolBRC: 📢New collaborative project on our site!. 'Handling missing data in large electronic healthcare record datasets'. Led by Pro….
0
3
0
RT @EricTopol: New @NatureMedicine.The longest randomized trial assessment—4 years— of semaglutide (Wegovy) in participants without diabete….
0
262
0
RT @CAUSALab: The 17th Kolokotrones Symposium, "UK Secure Data Environments: A New Approach to Population-Scale Real World Evidence,” was a….
0
5
0
RT @BristolBRC: 📢Paper alert!.Read about ROBINS-E, a new tool for assessing risk of bias in observational studies of exposures. Paper by Pr….
0
5
0
RT @CAUSALab: @_MiguelHernan & @jonathanasterne kick off the 17th Kolokotrones Symposium - UK Secure Data Environments: A New Approach to P….
0
2
0
RT @Caketin_Wade: Excited to be part of the Bristol-Bordeaux Public Health Meeting 2024! Looking forward to the diverse set of talks over t….
0
4
0
RT @JAMA_current: Compared with no invitation for routine PSA testing, a single invitation for a PSA screening test reduced prostate cancer….
0
25
0
This was a huge amount of work over many years. Thanks to all who participated in developing ROBINS-E!.
1
11
58